These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38082101)

  • 1. Clinical characteristics of hepatitis-associated aplastic anemia in children.
    Fu L; Zhang J; Wang R; Yang B; Li H; Chen H; Ma J
    Ann Hematol; 2024 Feb; 103(2):397-404. PubMed ID: 38082101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis-associated aplastic anaemia: clinical characteristics and immunosuppressive therapy outcomes].
    Yang WR; Jing LP; Zhou K; Peng GX; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Yang Y; Zhang FK; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):399-404. PubMed ID: 27210875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term Follow-up of Patients with Hepatitis-Associated Aplastic Anemia].
    You YH; Meng XB; Li XX; Ge ML; Nie N; Huang JB; Zhang J; Huang ZD; Shao YQ; Shi J; Zheng YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1130-1135. PubMed ID: 28823281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia.
    Ma X; Zuo Y; Xu Z; Zhang Y; Cheng Y; Han T; Suo P; Sun Y; Tang F; Wang F; Yan C; Chen Y; Wang Y; Zhang X; Liu K; Huang X; Xu L
    Ann Hematol; 2022 Aug; 101(8):1815-1823. PubMed ID: 35739427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features of hepatitis-associated aplastic anemia in children].
    Duan YL; Wu RH; Yang S; Zhang R; Zhang L; Zhou X; Jiang J; Jin M
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Aug; 12(8):609-12. PubMed ID: 20704790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Severe Seronegative Hepatitis-associated Aplastic Anemia: A Pediatric Case Series.
    Kemme S; Stahl M; Brigham D; Lovell MA; Nakano T; Feldman AG; Mack C
    J Pediatr Gastroenterol Nutr; 2021 Feb; 72(2):194-201. PubMed ID: 32925550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-laboratory variants of the course and results of therapy of hepatitis-associated aplastic anemias in children].
    Novichkova GA; Maschan MA; Kravchenko EG; Baĭdil'dina DD; Bogacheva NIu; Goronkova OV; Zharikova LI; Litvinov DV; Solopova GG; Suntsova EV; Shneĭder MM; Khachatrian LA; Skorobogatova EV; Shipitsyna IP; Trakhtman PE; Balashov DN; Maschan AA
    Ter Arkh; 2007; 79(7):57-61. PubMed ID: 17802792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Efficacy and Influencing Factors of Cyclosporine Alone in the Treatment of Children with Acquired Aplastic Anemia].
    Qin HC; Guan XM; Hu YN; Lei XY; Dou Y; Yu J; Wen XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):841-846. PubMed ID: 38926977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.
    Yang W; Zhao X; Peng G; Zhang L; Jing L; Zhou K; Li Y; Ye L; Li Y; Li J; Fan H; Yang Y; Zhang F
    Ann Hematol; 2021 Oct; 100(10):2435-2441. PubMed ID: 34269836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation.
    Safadi R; Or R; Ilan Y; Naparstek E; Nagler A; Klein A; Ketzinel-Gilaad M; Ergunay K; Danon D; Shouval D; Galun E
    Bone Marrow Transplant; 2001 Jan; 27(2):183-90. PubMed ID: 11281388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and immune characteristics of patients with hepatitis-associated aplastic anemia in China.
    Wang H; Tu M; Fu R; Wu Y; Liu H; Xing L; Shao Z
    PLoS One; 2014; 9(5):e98142. PubMed ID: 24845454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
    Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of five cases of hepatitis associated aplastic anemia presenting with hemophagocytic lymphohistiocytosis at onset].
    Wei A; Ma HH; Zhang LP; Wu RH; Zhang R; Wang TY
    Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):213-217. PubMed ID: 32135593
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia.
    Chen HF; Xu BX; Shen HS; Li ZY; Jin LJ; Tang JQ; Wang J; Zhu JJ; Qin LM; Cui QY; Ren YY; Wu TQ
    Drug Des Devel Ther; 2014; 8():1299-305. PubMed ID: 25246771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic Stem Cell Transplantation for Hepatitis-associated Aplastic Anemia Following Liver Transplantation for Nonviral Hepatitis: A Retrospective Analysis and a Review of the Literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.
    Mohseny AB; Eikema DA; Neven B; Kröger N; Shaw PJ; Damaj G; Dalle JH; Bosman PV; Delehaye F; Lankester AC; Smiers FJ; Peffault de Latour R
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1025-e1029. PubMed ID: 33273414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Outcomes for Hepatitis-associated Acquired Aplastic Anemia: 2 Case Studies and Review of the Literature.
    Lapinski J; Nolfi-Donegan D; Cooper JD; Squires RH
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):195-199. PubMed ID: 32815884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis-associated aplastic anemia.
    Zhang X; Yang W; Yang D; Wei J; Zhang P; Feng S; Jiang E; Zhang L; He Y; Zhang F; Han M
    Front Immunol; 2023; 14():1146997. PubMed ID: 37006284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.